相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study (vol 8, pg 889, 2009)
P. O'Connor
LANCET NEUROLOGY (2012)
Natalizumab prevents the accumulation of cortical lesions in relapsing remitting multiple sclerosis: a preliminary report
F. Rinaldi et al.
NEUROLOGICAL SCIENCES (2011)
A case of multiple sclerosis presenting with inflammatory cortical demyelination
B. F. Gh. Popescu et al.
NEUROLOGY (2011)
Inflammatory Cortical Demyelination in Early Multiple Sclerosis
Claudia F. Lucchinetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study (vol 8, pg 889, 2009)
P. O'Connor et al.
LANCET NEUROLOGY (2011)
Cerebral Pseudoatrophy or Real Atrophy After Therapy in Multiple Sclerosis
Samia Khoury et al.
ANNALS OF NEUROLOGY (2010)
Natalizumab Reduces Clinical and MRI Activity in Multiple Sclerosis Patients with High Disease Activity: Results from a Multicenter Study in Switzerland
Norman Putzki et al.
EUROPEAN NEUROLOGY (2010)
Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis
M. Calabrese et al.
NEUROLOGY (2010)
Cortical Lesions and Atrophy Associated With Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis
Massimiliano Calabrese et al.
ARCHIVES OF NEUROLOGY (2009)
Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study
Eva Havrdova et al.
LANCET NEUROLOGY (2009)
Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study
M. Calabrese et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Accumulation of cortical lesions in MS: relation with cognitive impairment
S. D. Roosendaal et al.
MULTIPLE SCLEROSIS (2009)
Cortical lesions in primary progressive multiple sclerosis A 2-year longitudinal MR study
M. Calabrese et al.
NEUROLOGY (2009)
250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study (vol 8, pg 889, 2009)
P. O'Connor et al.
LANCET NEUROLOGY (2009)
250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study
Paul O'Connor et al.
LANCET NEUROLOGY (2009)
Extensive cortical inflammation is associated with epilepsy in multiple sclerosis
Massimiliano Calabrese et al.
JOURNAL OF NEUROLOGY (2008)
Getting specific: monoclonal antibodies in multiple sclerosis
Andreas Lutterotti et al.
LANCET NEUROLOGY (2008)
Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial
Daniel D. Mikol et al.
LANCET NEUROLOGY (2008)
Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis
Massimiliano Calabrese et al.
ARCHIVES OF NEUROLOGY (2007)
MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS
D. H. Miller et al.
NEUROLOGY (2007)
Regression to the mean in multiple sclerosis
S. Martinez-Yelamos et al.
MULTIPLE SCLEROSIS JOURNAL (2006)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
RA Rudick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
Cortical demyelination and diffuse white matter injury in multiple sclerosis
A Kutzelnigg et al.
BRAIN (2005)
Intracortical lesions in multiple sclerosis: Improved detection with 3D double inversion-recovery MR imaging
JJG Geurts et al.
RADIOLOGY (2005)
Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes
CM Dalton et al.
BRAIN (2004)
Interferon-β-1b slows progression of atrophy in RRMS -: Three-year follow-up in NAb- and NAb+ patients
JA Frank et al.
NEUROLOGY (2004)
Focal thinning of the cerebral cortex in multiple sclerosis
M Sailer et al.
BRAIN (2003)
The clinico-radiological paradox in multiple sclerosis revisited
F Barkhof
CURRENT OPINION IN NEUROLOGY (2002)
Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions
JW Peterson et al.
ANNALS OF NEUROLOGY (2001)
A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis
R Zivadinov et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
Measuring the thickness of the human cerebral cortex from magnetic resonance images
B Fischl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
